News & Media

Who we are:

Fosun Pharma USA Inc. established in 2017, is a subsidiary of a leading global healthcare group, Fosun Pharma (SSE: 600196) (SEHK:2196) and Fosun International Limited (SEHK: 656), a leading conglomerate and investment company.

Fosun Pharma USA, Inc.

fast growing pharmaceutical company bringing products to market to improve patient access to medicine and innovation

About Us
Our company embodies an entrepreneurial spirit dedicated to improving the lives of patients and their families through innovative, accessible and affordable healthcare. With global manufacturing capabilities, Fosun Pharma USA remains agile to market changes and is open to opportunities in several therapeutic categories for both branded and generic products.

Fosun Pharma USA is a fast growing pharmaceutical company bringing products to market to improve patient access to medicine

Specialty Injectables

Superior quality and reliable supply of cost-effective generic injectables

Business Development

Partnerships to in-license or acquire innovative and generic products

FUSION Hub

Fosun Pharma US Innovation Hub (FUSION) invests in early-stage portfolio companies

Who we are:

Fosun Pharma USA Inc. established in 2017, is a subsidiary of a leading global healthcare group, Fosun Pharma (SSE: 600196) (SEHK:2196) and Fosun International Limited (SEHK: 656), a leading conglomerate and investment company.

fosun pharma usa, inc., guiding principles

Innovation, research and development, excellence in quality, supply reliability and patient affordability are core driving factors of Fosun Pharma USA. Based in Princeton, New Jersey, Fosun Pharma USA markets specialty injectables, develops partnerships to bring late-stage assets to the U.S. and China markets, and seeks investment opportunities with cutting-edge healthcare technologies through FUSION, our drug discovery incubator.

Learn more about us!